ANGLE plc (LON:AGL – Get Free Report) shares crossed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of GBX 2.35 and traded as high as GBX 2.90. ANGLE shares last traded at GBX 2.35, with a volume of 1,682,496 shares.
ANGLE Stock Performance
The company has a debt-to-equity ratio of 31.35, a current ratio of 3.13 and a quick ratio of 6.18. The company’s 50-day moving average price is GBX 2.35 and its two-hundred day moving average price is GBX 2.35. The company has a market capitalization of £7.58 million, a price-to-earnings ratio of -0.49 and a beta of 0.22.
About ANGLE
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD. ANGLE plc has a partnership agreement with Bio View Ltd to develop a liquid biopsy circulating tumor cell HER2 assay for breast cancer. The company was founded in 1994 and is based in Guildford, the United Kingdom.
Further Reading
- Five stocks we like better than ANGLE
- 3 Stocks Rallying on Micron’s Price Boost: Substance or Hype?
- Snowflake and the Snowballing Impact of its AI Flywheel
- AI’s Biggest Bottleneck Could Make These 2 Stocks Soar
- These 3 Beaten-Down Stocks Just Saw $25 Million in Insider Buying
Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.
